Folic acid functionalized nanoparticles for enhanced oral drug delivery

Emilie Roger, Stephen Kalscheuer, Ameya Kirtane, Bharath Raja Guru, Alex E. Grill, Judith Whittum-Hudson, Jayanth Panyam

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

The oral absorption of drugs that have poor bioavailability can be enhanced by encapsulation in polymeric nanoparticles. Transcellular transport of nanoparticle-encapsulated drug, possibly through transcytosis, is likely the major mechanism through which nanoparticles improve drug absorption. We hypothesized that the cellular uptake and transport of nanoparticles can be further increased by targeting the folate receptors expressed on the intestinal epithelial cells. The objective of this research was to study the effect of folic acid functionalization on transcellular transport of nanoparticle- encapsulated paclitaxel, a chemotherapeutic with poor oral bioavailability. Surface-functionalized poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles loaded with paclitaxel were prepared by the interfacial activity assisted surface functionalization technique. Transport of paclitaxel-loaded nanoparticles was investigated using Caco-2 cell monolayers as an in vitro model. Caco-2 cells were found to express folate receptor and the drug efflux protein, p-glycoprotein, to high levels. Encapsulation of paclitaxel in PLGA nanoparticles resulted in a 5-fold increase in apparent permeability (P app) across Caco-2 cells. Functionalization of nanoparticles with folic acid further increased the transport (8-fold higher transport compared to free paclitaxel). Confocal microscopic studies showed that folic acid functionalized nanoparticles were internalized by the cells and that nanoparticles did not have any gross effects on tight junction integrity. In conclusion, our studies indicate that folic acid functionalized nanoparticles have the potential to enhance the oral absorption of drugs with poor oral bioavailability.

Original languageEnglish
Pages (from-to)2103-2110
Number of pages8
JournalMolecular Pharmaceutics
Volume9
Issue number7
DOIs
Publication statusPublished - 02-07-2012

Fingerprint

Folic Acid
Nanoparticles
Pharmaceutical Preparations
Paclitaxel
Transcytosis
Caco-2 Cells
Biological Availability
Drug Receptors
Tight Junctions
Permeability
Glycoproteins
Epithelial Cells

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Roger, E., Kalscheuer, S., Kirtane, A., Guru, B. R., Grill, A. E., Whittum-Hudson, J., & Panyam, J. (2012). Folic acid functionalized nanoparticles for enhanced oral drug delivery. Molecular Pharmaceutics, 9(7), 2103-2110. https://doi.org/10.1021/mp2005388
Roger, Emilie ; Kalscheuer, Stephen ; Kirtane, Ameya ; Guru, Bharath Raja ; Grill, Alex E. ; Whittum-Hudson, Judith ; Panyam, Jayanth. / Folic acid functionalized nanoparticles for enhanced oral drug delivery. In: Molecular Pharmaceutics. 2012 ; Vol. 9, No. 7. pp. 2103-2110.
@article{6ffeb0c8e19040c3a1c2788453324e3d,
title = "Folic acid functionalized nanoparticles for enhanced oral drug delivery",
abstract = "The oral absorption of drugs that have poor bioavailability can be enhanced by encapsulation in polymeric nanoparticles. Transcellular transport of nanoparticle-encapsulated drug, possibly through transcytosis, is likely the major mechanism through which nanoparticles improve drug absorption. We hypothesized that the cellular uptake and transport of nanoparticles can be further increased by targeting the folate receptors expressed on the intestinal epithelial cells. The objective of this research was to study the effect of folic acid functionalization on transcellular transport of nanoparticle- encapsulated paclitaxel, a chemotherapeutic with poor oral bioavailability. Surface-functionalized poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles loaded with paclitaxel were prepared by the interfacial activity assisted surface functionalization technique. Transport of paclitaxel-loaded nanoparticles was investigated using Caco-2 cell monolayers as an in vitro model. Caco-2 cells were found to express folate receptor and the drug efflux protein, p-glycoprotein, to high levels. Encapsulation of paclitaxel in PLGA nanoparticles resulted in a 5-fold increase in apparent permeability (P app) across Caco-2 cells. Functionalization of nanoparticles with folic acid further increased the transport (8-fold higher transport compared to free paclitaxel). Confocal microscopic studies showed that folic acid functionalized nanoparticles were internalized by the cells and that nanoparticles did not have any gross effects on tight junction integrity. In conclusion, our studies indicate that folic acid functionalized nanoparticles have the potential to enhance the oral absorption of drugs with poor oral bioavailability.",
author = "Emilie Roger and Stephen Kalscheuer and Ameya Kirtane and Guru, {Bharath Raja} and Grill, {Alex E.} and Judith Whittum-Hudson and Jayanth Panyam",
year = "2012",
month = "7",
day = "2",
doi = "10.1021/mp2005388",
language = "English",
volume = "9",
pages = "2103--2110",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "7",

}

Roger, E, Kalscheuer, S, Kirtane, A, Guru, BR, Grill, AE, Whittum-Hudson, J & Panyam, J 2012, 'Folic acid functionalized nanoparticles for enhanced oral drug delivery', Molecular Pharmaceutics, vol. 9, no. 7, pp. 2103-2110. https://doi.org/10.1021/mp2005388

Folic acid functionalized nanoparticles for enhanced oral drug delivery. / Roger, Emilie; Kalscheuer, Stephen; Kirtane, Ameya; Guru, Bharath Raja; Grill, Alex E.; Whittum-Hudson, Judith; Panyam, Jayanth.

In: Molecular Pharmaceutics, Vol. 9, No. 7, 02.07.2012, p. 2103-2110.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Folic acid functionalized nanoparticles for enhanced oral drug delivery

AU - Roger, Emilie

AU - Kalscheuer, Stephen

AU - Kirtane, Ameya

AU - Guru, Bharath Raja

AU - Grill, Alex E.

AU - Whittum-Hudson, Judith

AU - Panyam, Jayanth

PY - 2012/7/2

Y1 - 2012/7/2

N2 - The oral absorption of drugs that have poor bioavailability can be enhanced by encapsulation in polymeric nanoparticles. Transcellular transport of nanoparticle-encapsulated drug, possibly through transcytosis, is likely the major mechanism through which nanoparticles improve drug absorption. We hypothesized that the cellular uptake and transport of nanoparticles can be further increased by targeting the folate receptors expressed on the intestinal epithelial cells. The objective of this research was to study the effect of folic acid functionalization on transcellular transport of nanoparticle- encapsulated paclitaxel, a chemotherapeutic with poor oral bioavailability. Surface-functionalized poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles loaded with paclitaxel were prepared by the interfacial activity assisted surface functionalization technique. Transport of paclitaxel-loaded nanoparticles was investigated using Caco-2 cell monolayers as an in vitro model. Caco-2 cells were found to express folate receptor and the drug efflux protein, p-glycoprotein, to high levels. Encapsulation of paclitaxel in PLGA nanoparticles resulted in a 5-fold increase in apparent permeability (P app) across Caco-2 cells. Functionalization of nanoparticles with folic acid further increased the transport (8-fold higher transport compared to free paclitaxel). Confocal microscopic studies showed that folic acid functionalized nanoparticles were internalized by the cells and that nanoparticles did not have any gross effects on tight junction integrity. In conclusion, our studies indicate that folic acid functionalized nanoparticles have the potential to enhance the oral absorption of drugs with poor oral bioavailability.

AB - The oral absorption of drugs that have poor bioavailability can be enhanced by encapsulation in polymeric nanoparticles. Transcellular transport of nanoparticle-encapsulated drug, possibly through transcytosis, is likely the major mechanism through which nanoparticles improve drug absorption. We hypothesized that the cellular uptake and transport of nanoparticles can be further increased by targeting the folate receptors expressed on the intestinal epithelial cells. The objective of this research was to study the effect of folic acid functionalization on transcellular transport of nanoparticle- encapsulated paclitaxel, a chemotherapeutic with poor oral bioavailability. Surface-functionalized poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles loaded with paclitaxel were prepared by the interfacial activity assisted surface functionalization technique. Transport of paclitaxel-loaded nanoparticles was investigated using Caco-2 cell monolayers as an in vitro model. Caco-2 cells were found to express folate receptor and the drug efflux protein, p-glycoprotein, to high levels. Encapsulation of paclitaxel in PLGA nanoparticles resulted in a 5-fold increase in apparent permeability (P app) across Caco-2 cells. Functionalization of nanoparticles with folic acid further increased the transport (8-fold higher transport compared to free paclitaxel). Confocal microscopic studies showed that folic acid functionalized nanoparticles were internalized by the cells and that nanoparticles did not have any gross effects on tight junction integrity. In conclusion, our studies indicate that folic acid functionalized nanoparticles have the potential to enhance the oral absorption of drugs with poor oral bioavailability.

UR - http://www.scopus.com/inward/record.url?scp=84863325067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863325067&partnerID=8YFLogxK

U2 - 10.1021/mp2005388

DO - 10.1021/mp2005388

M3 - Article

C2 - 22670575

AN - SCOPUS:84863325067

VL - 9

SP - 2103

EP - 2110

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 7

ER -

Roger E, Kalscheuer S, Kirtane A, Guru BR, Grill AE, Whittum-Hudson J et al. Folic acid functionalized nanoparticles for enhanced oral drug delivery. Molecular Pharmaceutics. 2012 Jul 2;9(7):2103-2110. https://doi.org/10.1021/mp2005388